UBA2 as a Prognostic Biomarker and Potential Therapeutic Target in Glioma
Background: Gliomas are characterized by aggressive behavior, leading to severe disability and high mortality.Ubiquitin-like modifier activating enzyme 2 (UBA2) is a subunit of the E1-activating enzyme involved in the SUMOylation (SUMO, small ubiquitin-related modifier) of numerous proteins.Although the abnormality of UBA2 is linked to the progress